Search the Newsreel

Labcorp Holdings Inc. (NYSE:LH) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Labcorp Holdings Inc. (NYSE:LH) has received a consensus "Moderate Buy" rating from twelve brokerages, with an average 12-month price target of $330.00. The company recently surpassed quarterly earnings expectations with $4.99 EPS and $3.73 billion in revenue, and declared a quarterly dividend of $0.72 …

Abbott Laboratories (NYSE:ABT) Receives Consensus Rating of "Moderate Buy" from Brokerages

Abbott Laboratories (NYSE:ABT) has received a consensus "Moderate Buy" rating from twenty-six brokerages, with an average 12-month price target of $118.17. The company recently exceeded quarterly expectations with adjusted EPS of $1.31 and revenue of $12.59 billion, and announced a quarterly dividend of $0.63 …

Dr. Reddy's Laboratories slides Wednesday, underperforms competitors

Dr. Reddy's Laboratories Ltd. shares fell 0.50% on Wednesday to 1,198.95 Indian rupees, underperforming the broader market as the BSE SENSEX Index dropped 0.24%. The company's stock closed 15.23% below its 52-week high achieved on June 29th.

Borr Drilling: Q2 Earnings Snapshot

The article "Borr Drilling: Q2 Earnings Snapshot" is a placeholder for an earnings report. The current content is empty except for a privacy protection message, indicating that the actual financial details for Borr Drilling's Q2 earnings are not yet available or were not included …

Barclays Adjusts Price Target on IDEXX Laboratories to $710 From $800, Keeps Overweight Rating

Barclays has updated its price target for IDEXX Laboratories (IDXX), lowering it to $710 from the previous $800. Despite this adjustment, the firm has decided to maintain its Overweight rating on the stock. This indicates a continued positive outlook on the company's performance, even …

Borr Drilling Reports Quarterly Loss

Borr Drilling reported a significant net loss of $241.4 million in Q2 2026, primarily due to a large debt extinguishment charge, despite generating $232.3 million in operating revenues. The company's adjusted EBITDA decreased by 51% to $43.8 million, attributed to delays with the Odin …

IDEXX launches in-clinic cardiac test for cats and dogs

IDEXX Laboratories Inc. has launched the Catalyst proBNP Test, an in-clinic diagnostic tool for heart disease in cats and dogs. This test measures the NT-proBNP biomarker, providing rapid quantitative results to veterinarians for screening, diagnosis, and monitoring of cardiac conditions. The test will be …

JHS Svendgaard Laboratories consolidated net profit rises 2.83% in the June 2026 quarter

IDEXX Laboratories (IDXX) Unveils First Dual Species Cardiac Test For Dogs And Cats

Borana Weaves standalone net profit rises 35.08% in the June 2026 quarter

Borr Drilling Completes $287M Purchase of Five Jack-Up Rigs

Borr Drilling reported a Q2 2026 net loss of $241.4 million, heavily impacted by a $176.3 million debt extinguishment charge related to refinancing. Despite the loss, the company secured $541 million in new contracts year-to-date and completed the acquisition of five premium jack-up rigs …

If EPS Growth Is Important To You, Arvee Laboratories (India) (NSE:ARVEE) Presents An Opportunity

¿Puede Abbott Laboratories (ABT) Estar 8% Infravalorada Tras Mejorar Su Previsión Anual?

Carborundum Universal Limited Just Missed EPS By 27%: Here's What Analysts Think Will Happen Next

Bio-Rad (BIO) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 5 p.m. ET CALL PARTICIPANTS Head of Investor Relations - Ruben ArguetaChief Executive Officer - Norman SchwartzPresident and Chief Operating Officer - Jonathan DiVincenzoExecutive Vice President and Chief Financial Officer - Roop Lakkaraju …

Borr Drilling Limited (BORR) Stock Falls on Q2 2026 Earnings

This document is the Q2 2026 Presentation for Borr Drilling Limited. It contains the company's financial results and operational updates for the second quarter of 2026.

Borr Drilling Q2 revenue falls q-o-q on lower rig count

Abbott Laboratories (ABT) schedules NYSE sale of stock from vested awards

Abbott Laboratories (ABT) has filed a Form 144 indicating a planned sale of 5,850 common shares through UBS Financial Services on or after August 11, 2026, on the NYSE. The shares originate from vested restricted stock awards granted on February 27, 2026, totaling 1,960, …

Charles River Laboratories International Inc. stock outperforms competitors on strong trading day

Charles River Laboratories International Inc. (CRL) saw its stock advance by 1.81% to $282.00 on Tuesday, marking its sixth consecutive day of gains. This performance stood out on a generally grim trading day where the S&P 500 Index fell 0.32% and the Dow Jones …

Insider Selling: Charles River Laboratories International (NYSE:CRL) Director Sells $7,901,575.00 in Stock

Charles River Laboratories International Director James Foster sold 28,733 shares of NYSE:CRL stock for approximately $7.9 million at an average price of $275, reducing his direct ownership by 47.63%. This transaction, conducted under a pre-arranged Rule 10b5-1 trading plan, comes amidst generally positive analyst …

Silicon Laboratories (SLAB) Beats Q2 Earnings Estimates

Silicon Laboratories (SLAB) came out with quarterly earnings of $0.71 per share, beating the Zacks Consensus Estimate of $0.67 per share. This compares to earnings of $0.11 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …

IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors

IDEXX Laboratories Inc. (IDXX) stock fell 1.53% on Tuesday, closing at $586.64, despite a general downturn in the stock market. The S&P 500 Index and Dow Jones Industrial Average also saw declines of 0.32% and 0.34%, respectively. The company's stock is now 23.81% below …

Borr Drilling tjente null – utfordres av bråk i Persiabukten

Charles River Laboratories (CRL) EVP LaPlume reports bona fide gift of 257 shares

Joseph W. LaPlume, EVP, Corp Strategy & Develop at Charles River Laboratories International, Inc. (CRL), reported a bona fide gift of 257 shares of common stock on August 10, 2026. This transaction was a disposition at a reported per-share price of $0.00, leaving LaPlume …

Charles River (CRL) director James C. Foster exercises options and sells 28,733 shares

Charles River Laboratories International director James C. Foster exercised stock options for 28,733 shares at $179.66 per share and immediately sold them at $275.00 per share on August 10, 2026, pursuant to a Rule 10b5-1 Trading Plan. This transaction resulted in an approximate pre-tax …

Silicon Laboratories (SLAB) Releases Q2 2026 Earnings: Revenue Up 18.3% but Losses Persist

Arbor Realty Trust Can Add About $56.7M in Loans for Up to 180 Days

Arbor Realty Trust Closes $825 Million Collateralized Loan Obligation Securitization

Arbor Realty Trust UNIONDALE, N.Y., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Arbor Realty Trust, Inc. (NYSE: ABR), today announced the closing of an $825 million commercial real estate mortgage loan securitization (the "Securitization"). An aggregate of approximately $730.1 million of investment grade-rated notes were …

Grove Collaborative receives NYSE non-compliance notice By Investing.com

Grove Collaborative Holdings Inc. (NYSE:GROV) has received a notice from the New York Stock Exchange for non-compliance with listing standards. The company failed to meet the requirement of an average global market capitalization of at least $50 million and stockholders' equity of at least …

Earnings Flash (SLAB) Silicon Laboratories Inc. Posts Q2 Adjusted EPS $0.71 per Share, vs. FactSet Est of $0.69

Earnings Flash (SLAB) Silicon Laboratories Inc. Reports Q2 Revenue $228.2M, vs. FactSet Est of $228.0M

Silicon Laboratories Inc. (SLAB) reported its Q2 revenue at $228.2 million, surpassing the FactSet estimate of $228.0 million. This financial update indicates a slight beat on revenue expectations for the second quarter. The company also reported Q2 adjusted EPS of $0.71 per share, exceeding …

Silicon Labs (NASDAQ: SLAB) grows Q2 sales as $231-per-share TI merger advances

Silicon Laboratories Inc. reported increased Q2 2026 sales to $228.2 million, up from $192.8 million the previous year, driven by both Industrial & Commercial and Home & Life products, with gross margin improving to 61.6%. Despite revenue growth, the company incurred a net loss …

Silicon Laboratories (NASDAQ:SLAB) Posts Earnings Results, Beats Expectations By $0.02 EPS

Silicon Laboratories (NASDAQ:SLAB) announced its quarterly earnings, surpassing analyst expectations with an EPS of $0.71 against a consensus of $0.69, and revenue of $228.19 million. The stock increased to $218.94, nearing its 52-week high, bringing its market capitalization to approximately $7.22 billion. Despite the …

Silicon Labs Reports Second Quarter 2026 Results

Silicon Labs reported strong financial results for the second quarter of 2026, with revenue reaching $228 million, an 18% increase year-over-year. The company saw significant growth in its Industrial & Commercial and Medical segments, along with improved profitability and a non-GAAP diluted earnings per …

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SEC Filing (Aug 11, 2026)

This SEC filing (Form 144) for Charles River Laboratories International, Inc. (CRL) details a proposed sale of 6,500 shares of common stock, valued at $1,819,350.00, acquired through the exercise of stock options on August 11, 2026. The transaction was handled by UBS Financial Services, …

Oaktree invests $1.5B in United Wholesale Mortgage as Ishbia scrambles

Oaktree Capital Management has invested $1.5 billion in United Wholesale Mortgage (UWM), a move seen by some as a bailout for the struggling mortgage lender. UWM's shares plummeted after the announcement, coupled with the suspension of common-stock dividends, and the company is also suing …